流感板块午后再度拉升，凯普生物20cm涨停

Core Viewpoint - The influenza sector experienced a significant rally in the afternoon, with multiple companies showing substantial gains, indicating a positive market sentiment towards the industry [1] Group 1: Company Performance - Capbio reached a 20% limit up, reflecting strong investor interest and confidence in its performance [1] - Zhifei Biological and Wanfu Biological both saw their stock prices increase by over 10%, showcasing robust market activity [1] - Zhijiang Biological and Hualan Vaccine previously hit the limit up, indicating strong demand and positive market conditions [1] - Companies such as CanSino, Shuoshi Biological, and Kehua Biological also reported notable gains, further highlighting the overall positive trend in the sector [1]